Sanofi is a pharmaceutical company that researches, develops, manufactures, and markets drugs and vaccines across multiple therapeutic areas including immunology, inflammation, rare diseases, neurology, and oncology. Its vaccine portfolio includes formulations for polio, pertussis, and influenza, as well as combination vaccines protecting against hepatitis A, typhoid, yellow fever, and rabies. The company maintains numerous partnerships with biotechnology firms to advance treatments in areas such as oncology, neurological disorders, inflammatory diseases, and cell therapy, while also collaborating on artificial intelligence platforms and genome editing technologies for drug development.
1Y: 44.74 (-5.7%) · range 39.12–49.59
entry readiness 38 · WEAK SETUP · exit proximity 0
Value area 41.60–45.12 · 11% of 120d volume overhead · clean runway
| Source | Score | Last seen |
|---|---|---|
| earnings-surprise | 0.900 | Nov 2, 2026 |
Not yet labeled — the study prices these as positions mature.